Upcoming workshop: Unlocking the complexity of rare diseases through knowledge graphs

Upcoming workshop Unlocking the complexity of rare diseases through knowledge graphs

Understanding the intricate biological mechanisms underlying rare diseases remains one of the greatest challenges in biomedical research. In response to this complexity,ERDERA is pleased to host theRare Disease Maps Workshop—a two-day virtual event designed to explore how knowledge graphs and disease mapping can advance research in this field.

The workshop will bring together researchers, data scientists, and healthcare professionals to examine how network-based approaches are being used to shed light on the pathways and mechanisms associated with rare diseases. Attendees will gain insights into the development and application of disease maps—tools that have already demonstrated significant potential in identifying drug targets, biomarkers, and other key molecular interactions.

Participants will have the opportunity to:

  • Explore current methods for building and analysing rare disease maps, along with available tools and data resources.
  • Learn from real-world case studies where disease maps have supported hypothesis generation and therapeutic discovery.
  • Discover how these methodologies can be applied to their own research to create actionable knowledge graphs.

This event is ideal for anyone looking to translate complex research questions into structured, visual representations of disease mechanisms.

Registration is now open for both sessions of the workshop:

Join ERDERA and take the next step in transforming rare disease research through the power of knowledge graphs.

News & Updates

You might also be interested in

ERDERA’s ethics and regulatory experts are launching a dedicated webinar series to help the rare disease research community navigate two fast-moving areas of biomedical research: Advanced Therapy Medicinal Products (ATMPs) and Artificial Intelligence.
July 24 @ 3:00 pm - 4:00 pm
This webinar will present a theoretical framework for situating ethics across research activities. The framework will then be brought to life through a relevant case study discussion, giving participants a concrete reference point for the episodes ahead.
ERDERA (the European Rare Diseases Research Alliance) has opened its Clinical Trial Call to support multinational early-phase clinical trials in rare diseases. The call will fund studies designed to generate robust clinical evidence, strengthen regulatory readiness and make rare disease trials more feasible across countries.
Call text draft setting out rules, eligibility and staged application process for the ERDERA Clinical Trial Call 2026.